Quick answer
Mounjaro (tirzepatide) causes more weight loss than diet alone: in the SURMOUNT-1 trial, people lost an average of 15% to 21% of body weight over 72 weeks, compared with about 3% on diet advice plus placebo. But diet-based weight loss has no injection side effects, protects muscle when planned well, costs far less and does not depend on staying on a drug. In SURMOUNT-4, people who stopped Mounjaro regained about 14% of body weight within a year. The best choice depends on your weight, health conditions, budget and goals — and food quality matters either way.
Key takeaways
- Mounjaro is a weekly tirzepatide injection that acts on two gut hormones, GIP and GLP-1.
- Average weight loss in trials was about 15% (5 mg) to 21% (15 mg) over 72 weeks.
- Stomach side effects are common, and much of the weight returns when it is stopped.
- A well-planned diet gives smaller but durable results and improves blood sugar and fatty liver for many people.
- Mounjaro is not a replacement for good nutrition — it makes nutrition more important.
What is Mounjaro used for?
Mounjaro contains tirzepatide, a once-weekly injection that activates both GIP and GLP-1 receptors. It was first approved for type 2 diabetes to lower blood sugar, and in many countries — including India, where it was launched in 2025 — it is also approved for chronic weight management in adults with obesity, or overweight with weight-related health problems. In the US, the weight-loss version is sold as Zepbound. Learn what GLP-1 is and how these drugs work.
Mounjaro weight loss results
SURMOUNT-1 followed 2,539 adults with obesity or overweight (without diabetes) for 72 weeks. Everyone received lifestyle counselling. Average weight loss was 15.0% on 5 mg, 19.5% on 10 mg and 20.9% on 15 mg, compared with 3.1% on placebo. These are among the largest results ever seen with a medicine for weight loss, and blood pressure, cholesterol and blood sugar improved as well.
Mounjaro side effects
The most common side effects are nausea, diarrhoea, vomiting, constipation, indigestion and loss of appetite, mostly mild to moderate and most frequent during dose increases. Rarer serious risks include pancreatitis, gallbladder disease, dehydration with kidney strain and low blood sugar when used with insulin or sulfonylureas. It is not used in pregnancy or in people with a personal or family history of medullary thyroid cancer or MEN2. See the complete guide to GLP-1 side effects.
What diet alone achieves
Diet-only programmes usually produce 5% to 10% weight loss, and structured programmes with close follow-up can do more. In the DiRECT trial, a supervised diet programme in primary care led to type 2 diabetes remission in almost half of participants at one year. In the Diabetes Prevention Program and the Indian Diabetes Prevention Programme, lifestyle change with modest weight loss substantially reduced the risk of developing diabetes. These results come without injections or drug side effects.
Mounjaro vs diet: side-by-side
A simple comparison:
| Mounjaro (tirzepatide) | Personalised diet plan | |
|---|---|---|
| Average weight loss | About 15–21% over 72 weeks in SURMOUNT-1 | Usually 5–10%, higher with structured support |
| Appetite | Strongly reduced by the drug | Reduced gradually by protein, fibre and food quality |
| Side effects | Nausea, diarrhoea, vomiting, constipation; rare pancreatitis and gallbladder disease | Minimal when planned properly |
| Muscle | Risk of lean mass loss without enough protein and strength training | Protein and activity planned from the start |
| After stopping | About 14% of body weight regained within a year in SURMOUNT-4 | Habits continue; follow-up helps prevent regain |
| Ongoing cost | Monthly medicine cost, often long term | Mainly consultation; normal home food |
| Medical supervision | Essential | Recommended, especially with diabetes or medicines |
Why weight returns after stopping Mounjaro
In SURMOUNT-4, everyone took tirzepatide for 36 weeks and lost about 21% of body weight. Then half switched to placebo. Over the next year, the placebo group regained about 14% of body weight, while the group that continued lost a further 5.5%. Appetite returns when the drug stops — so if eating habits have not changed underneath, the weight follows. This is why Dr. Jai Vora treats nutrition as the foundation, whether or not medicine is used.
Combining Mounjaro with the right diet
If you and your doctor choose Mounjaro, nutrition decides how healthy your weight loss is:
- Protein at every meal — typically around 1.2–1.6 g per kg of body weight per day for many adults losing weight, as your doctor advises.
- Small portions of dal, curd, paneer, eggs, fish, chicken or tofu first; vegetables next; roti or rice last.
- Fibre from vegetables, millets, oats and fruit, added gradually to avoid bloating.
- Two to three litres of fluid a day unless your doctor restricts fluids.
- Strength training two or three times a week to protect muscle.
- Regular blood tests for B12, vitamin D, iron and other nutrients if intake is low.
When diet first makes more sense
A food-first plan is often the better starting point for mild to moderate excess weight, prediabetes, PCOS, fatty liver or early type 2 diabetes; for people who cannot tolerate or afford long-term medicine; for those planning pregnancy; and for older adults worried about muscle. Read how to lose weight without medication and the full Ozempic vs natural weight loss comparison.
Getting personal advice
There is no single right answer for everyone. Dr. Jai Vora reviews your reports, medicines, weight history and lifestyle, then builds a cellular nutrition plan that works on its own or alongside the treatment from your own doctor. Book an online consultation or read about the weight management programme.
Frequently asked questions
Is Mounjaro better than diet for weight loss?
Mounjaro causes more weight loss on average, but has side effects and ongoing cost, and most weight tends to return after stopping. Diet gives smaller but durable results without drug side effects. Many people benefit most from good nutrition with or without medicine.
How much weight can you lose on Mounjaro?
In SURMOUNT-1, average loss was 15% to 21% of body weight over 72 weeks, depending on dose. Individual results vary widely.
Do I still need to diet on Mounjaro?
Yes. Trials combined the drug with lifestyle counselling, and protein, fibre and fluids are needed to protect muscle, avoid deficiencies and reduce side effects.
Is Mounjaro available in India?
Yes. Mounjaro (tirzepatide) was launched in India in 2025. It is a prescription medicine to be used under medical supervision.
What happens if I stop Mounjaro?
Appetite returns, and in SURMOUNT-4 people who stopped regained about 14% of body weight within a year. A nutrition plan built during treatment improves the chance of keeping weight off.
100% Virtual Clinical Care Worldwide
Get a cellular nutrition plan built on your own reports
Every consultation and diet plan is handled personally by Dr. Jai Vora, by video call and WhatsApp.
References
- Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med. 2022;387:205–216. Source
- Aronne LJ, et al. Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity (SURMOUNT-4). JAMA. 2024;331(1):38–48. Source
- Frías JP, et al. Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes (SURPASS-2). N Engl J Med. 2021;385:503–515. Source
- European Medicines Agency. Mounjaro (tirzepatide) — EPAR product information. Source
- National Institute for Health and Care Excellence. Tirzepatide for managing overweight and obesity (TA1026). Source
- Lean MEJ, et al. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet. 2018;391:541–551. Source
- Knowler WC, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin (Diabetes Prevention Program). N Engl J Med. 2002;346:393–403. Source
- Ramachandran A, et al. The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia. 2006;49:289–297. Source
- Mozaffarian D, et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. Am J Clin Nutr. 2025;122(1):344–367. Source
- Neeland IJ, Linge J, Birkenfeld AL. Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies. Diabetes Obes Metab. 2024;26(Suppl 4):16–27. Source
- Cava E, Yeat NC, Mittendorfer B. Preserving healthy muscle during weight loss. Adv Nutr. 2017;8(3):511–519. Source
This article is for education only. Speak with your doctor before changing medication, diet or treatment.
More from the GLP-1 vs Natural Weight Loss guide
- Ozempic, Mounjaro & Wegovy vs Natural Weight Loss: The Complete Comparison
- Ozempic, Mounjaro & Wegovy vs Natural Weight Loss: GLP-1 Drugs Compared With a Food-First Cellular Nutrition Approach
- What Is GLP-1? How GLP-1 Weight Loss Drugs Like Ozempic, Wegovy and Mounjaro Work
- GLP-1 Side Effects: Ozempic, Wegovy and Mounjaro Side Effects Explained by a Doctor
- Natural Alternatives to Ozempic: 9 Food-Based Ways to Lose Weight Without Injections
- GLP-1 Muscle Loss and Nutritional Deficiencies: How to Protect Muscle on Ozempic, Wegovy or Mounjaro
- How to Lose Weight Without Medication: A Doctor's Plan for Sustainable, Food-Based Weight Management